The Department of Veterans Affairs says it's committed to studying the effectiveness of psychedelics like MDMA and psilocybin for post-traumatic stress disorder ahead of a House hearing expected to touch on the substances.
Why it matters: Confronted with a worsening mental health crisis and a shortage of psychiatrists, stakeholders ranging from government agencies and venture capital are recognizing psychedelics' potential role in treating mental illness.
